Jan Vijg, Ph.D., is Professor and Chairman of the Department of Genetics at the Albert Einstein College of Medicine in New York since July 2008. He received his Ph.D. at the University of Leiden, The Netherlands, in 1987. From 1990 to 1993 he was founder and Scientific Director of Ingeny B.V., a Dutch Biotechnology company. In 1993 he moved to Boston, to take up a position as Associate Professor of Medicine at Harvard Medical School. In 1998 he accepted an offer from the University of Texas Health Science Center in San Antonio, Texas, to become a Professor in the Department of Physiology.
From 2006 to 2008 he was a Professor at the Buck Institute for Age Research in Novato, California. With his research team, he was the first to develop transgenic mouse models for studying mutagenesis in vivo (in 1989) and has used these models ever since in studying the relationship between damage to the genome and aging. He has published well over 300 scientific articles and three books and is inventor or co-inventor on 8 patents. Dr. Vijg is the recipient of the Schreuder Award of the Netherlands Society of Gerontology (1987), the Nathan Shock New Investigator Award of The Gerontological Society of America (1994) and the Irving Wright Award of Distinction of the American Federation for Aging Research (2012). He is a Fellow of the American Association for the Advancement of Science (AAAS) and has been Chairman of the Board of Scientific Counselors of the National Institute on Aging’s Intramural Research Program from 2013 to 2015. He is currently Chair of the NIH study section NIAB. He has been Editor in Chief of the journal Mutation Research from 2015-2018. Dr. Vijg’s research has been continuously funded by the NIH since 1993.
Email: jan.vijg at einsteinmed.org